Angene Chemical
Draw
|
Currency :
Home Products

AG003THE

73590-58-6 | Omeprazole

Chemical structure of Omeprazole, CAS 73590-58-6
AG003THE
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 73590-58-6
Catalog Number AG003THE(AGN-PC-00TV5D)
Chemical Name Omeprazole
EC Number 615-996-8
IUPAC Name 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
InChI InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)
InChI Key SUBDBMMJDZJVOS-UHFFFAOYSA-N
MDL Number MFCD00083192
Molecular Formula C17H19N3O3S
Molecular Weight 345.4161
SMILES S(=O)(Cc1c(C)c(OC)c(cn1)C)c1nc2c([nH]1)ccc(c2)OC
Synonyms
H 168 68, H 168-68, H 16868, Magnesium, Omeprazole, Omeprazole, Omeprazole Magnesium, Omeprazole Sodium, Prilosec, Sodium, Omeprazole, omeprazole, 73590-58-6, Losec, Prilosec, Antra, Esomeprazole, Omeprazon, Audazol, Omapren, Omepral, Parizac, Zegerid, Mopral, Miol, Belmazol, Ceprandal, Dizprazol, Dudencer, Emeproton, Epirazole, Gastrimut, Gastroloc, Gibancer, Indurgan, Inhibitron, Inhipump, Logastric, Pepticum, Peptilcer, Prazidec, Sanamidol, Secrepina, Ulcometion, Mepral, Miracid, Omeprol, Omezol, Omisec, Omizac, Ompanyt, Ozoken, Prysma, Ramezol, Ulceral, Ulcesep, Ulcozol, Zefxon, Zoltum, Desec, Elgam, Lomac, Ulsen, Ultop, Zimor, Ocid, Omed, Omid, OMEP, Demeprazol, Nopramin, Omeprazol, Omezolan, Paprazol, Pepticus, Prazentol, Prazolit, Procelac, Regulacid, Danlox, Erbolin, Lensor, Morecon, Nilsec, Olexin, Omegast, Omesek, Ortanol, Osiren, Proclor, Result, Ulcsep, Victrix, Zepral, Exter, Gasec, Ulzol, Omebeta 20, Tedec Ulceral, AULCER, Antra MUPS, Omeprazolum, Omerprazole, Omez, Prilosec OTC, Omepradex, Nexium IV, H 168/68, Omeprazol [INN-Spanish], Omeprazolum [INN-Latin], Esomperazole, Gastrogard, Nuclosina, r-omeprazole, Omeprazole magnesium, ( -)-Omeprazole, Omesec, Prestwick_808, CCRIS 7099, OMZ, CHEBI:77260, HSDB 3575, Esomeprazole sodium salt, 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole, 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole, MFCD00083192, Nexium, H-168/68, CHEMBL1503, Nexiam, 1H-Benzimidazole, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-, 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole, 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole, MLS000069373, C17H19N3O3S, SUBDBMMJDZJVOS-UHFFFAOYSA-N, (+)-omeprazole, 2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole, Omeprazole, 98+%, NCGC00016925-06, SMR000058847, Emilok, CAS-73590-58-6, Esomeprazole Sodium, DSSTox_CID_1080, 5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole, 2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole, 6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole, DSSTox_RID_75929, UNII-S51HU491WJ, DSSTox_GSID_21080, Omeprazone, Omeprazen, Omeprazole delayed-release, Omeprazole Pellets, 5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole, 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole, (R)-Esomeprazole, Prilosec (TN), (+-)-Omeprazole, Omeprazole, (R)-, Omeprazole [USAN:INN:BAN:JAN], SR-01000003003, (s)-omeprazole sodium, R-Omeprazole [USP-RS], S51HU491WJ, Omperazole, SAN-15, 161796-78-7, Omeprazole, solid, 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole, 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]benzimidazole, 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole, AGI-010, Omeprazole,(S), H 168-68, DM-3458, Omeprazole [USAN:USP:INN:BAN:JAN], Omeprazole (Prilosec), ACMC-20p1du, AC1L1IIJ, Maybridge4_002645, Opera_ID_1863, Prestwick0_000493, Prestwick1_000493, Prestwick2_000493, Prestwick3_000493, (.+/-.)-Omeprazole, O0359, UPCMLD-DP075, cid_4594, SCHEMBL1191, BSPBio_000385, MLS001076112, MLS001424148, MLS006010400, MLS006011759, BIDD:GT0189, SPBio_002306, BPBio1_000425, GTPL4279, Omeprazole (JP17/USP/INN), Esomeprazole sodium salt hydrate, DTXSID6021080, SCHEMBL11995456, UPCMLD-DP075:001, CHEBI:91766, CTK8I2124, CTK9A5793, HMS1528I05, HMS1569D07, HMS2052G17, HMS2090E16, HMS2090F11, HMS2096D07, HMS2232B21, HMS3269D17, HMS3394G17, HMS3651A11, HMS3677J07, HMS3713D07, Pharmakon1600-01505693, (S)-Omeprazole sodium salt hydrate, BCP05852, BCP13592, BCP21299, HY-B0113, KS-000001KH, 2,3,5-Trimethylpyridine/Omeprazole, Tox21_110686, Tox21_200509, AC-401, BBL028172, BDBM50103597, BDBM50241343, CO0037, DL-462, NSC751450, NSC759192, s1389, STK623746, 119141-88-7 (base), AKOS005066653, AKOS015895343, Tox21_110686_1, AC-4676, CCG-101130, CCG-213517, CS-1868, DB00338, HS-0055, LS-7629, MCULE-3224208952, NC00380, NE55490, NSC-751450, NSC-759192, 1H-Benzimidazole, 6-methoxy-2-((R)-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-, 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole, IDI1_032523, NCGC00016925-01, NCGC00016925-02, NCGC00016925-03, NCGC00016925-04, NCGC00016925-05, NCGC00016925-07, NCGC00016925-08, NCGC00016925-10, NCGC00016925-11, NCGC00021522-03, NCGC00021522-04, NCGC00021522-05, NCGC00258063-01, Omeprazole, analytical reference material, AK162396, AN-11759, AN-15878, BC203197, BC226373, CPD000058847, K253, SAM001246900, SC-15162, SY077145, SBI-0206896.P001, AB0014122, AB1009257, TL8005099, FT-0601585, FT-0652860, FT-0653294, H 199, ST24048844, SW196942-4, MFCD00083192 (98%), A19447, C07324, D00455, J10125, 668985-31-7 (Mg), 141O887, A837865, H168/68, I06-0705, SR-01000003003-4, SR-01000003003-7, SR-01000003003-8, 5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl), BRD-A55962179-001-04-9, BRD-A55962179-001-08-0, BRD-A55962179-001-20-5, BRD-A88691025-001-07-4, I14-40975, F0001-2386, Z1672902589, Omeprazole, British Pharmacopoeia (BP) Reference Standard, Omeprazole, European Pharmacopoeia (EP) Reference Standard, Omeprazole, United States Pharmacopeia (USP) Reference Standard, 2-(3-methoxy-2,4-dimethylbenzylsulfinyl)-6-methoxy-1H-benzo[d]imidazole, 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2- pyridinyl)methyl)sulfinyl)-, Omeprazole, Pharmaceutical Secondary Standard; Certified Reference Material, (+)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-sulfinyl]-1h-benzimidazole, (-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-sulfinyl]-1h-benzimidazole, (RS)-5-Methoxy-2-(4-methoxy-3,5-dimethyl-2-pyridylmethylsulphinyl)benzimidazole, 1H-Benzimidazole,5-methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, 5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyrdinyl)-methyl]sulfinyl]-1H-benzimidazole, 5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1 H-benzimidazole, 5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, 5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole, 5-methoxy-2-(2-(4-methoxy-3,5-dimethylpyridin-2-yl)ethylsulfinyl)-1H-benzo[d]imidazole, 5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole, 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl- 1H-benzimidazole, 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-3H-benzoimidazole, 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-3H-1,3-benzodiazole, 5-Methoxy-2-[(RS)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-1H-benzimidazole, 5-methoxy-2-[[(3,5-dimethyl-4-methoxy-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphinyl]-1H-benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-benzimidazole, 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfonyl]benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphinyl]1H-benzimidazole, 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole, 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole, 6-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-1H-benzimidazole, 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole, 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1h-benzimidazole, 6-methoxy-2-[[(4-methoxy-3,5dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole, 6-methoxy-2-[[(4-methoxy3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole, 6-methoxy-2-[[(4methoxy-3,5-dimethyl2-pyridinyl)methyl]sulfinyl]-1h-benzimidazole, 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole, Omeprazole for peak identification, European Pharmacopoeia (EP) Reference Standard, Omeprazole solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, (omeprazole)5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole, (RS)-6-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl) methylsulfinyl)-1H-benzo[d]imidazole, 5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole (omeprazole), 5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole(Omeprazole), 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; Antra; Losec, 6-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt, Esopral, Axagon, Lucen, esomeprazol, Equiprazole, Gastrozole, Roweprazol, Megazole, Ovulanze, Omebeta, Omepril, Omezzol, Acidex, Omedar, Omelac, Omerap, Ulzone, Andra, Oprax, Opraz, Olit, Omeprazole-Towa, Losec Sodium, (-)-Omeprazole, Omeprazole-d3, Omeprazole powder, (r)-omeprazole, (S)-Omeprazole, (S)-Esomeprazole, Petprazol 20, OMEPRAZOLE SODIUM, Sodium, Omeprazole, Losec (TN), Magnesium, Omeprazole, Omeprazole, 98% 1g, H199/18 sodium, (S)-(-)-Omeprazole, H 168/68 sodium, Omeprazole Sulfone (AS), UNII-KV03YZ6QLW, Omeprazole sodium [USAN], D01XNB, UNII-L2C9GWQ43H, UNII-KG60484QX9, omeprazole sodium bicarbonate, Esomeprazole Sodium [USAN], C17H18N3NaO3S, Omeprazole (JAN/USP/INN), CID4594, KG60484QX9, Omeprazole [USAN:BAN:INN:JAN], C17-H18-N3-Na-O3-S, C17-H19-N3-O3-S.Na, C17-H19-N3-O3-S, methylsulfinyl)-1H-benzo[d]imidazole, 119141-88-7, ACN-052223, CS-O-10304, 1694A, A2845, Losec, Omesec, Prilosec, Zegerid, Omeprazole, 5-methoxy-2-[ methylsulfinyl]-3H-benzoimidazole, D009853, H 16868, 119141-89-8, H 168 68, Omeprazole, 98%, a proton pump inhibitor - 5G 5g, OMP, 1H-bencimidazol, [5-metoxi-2-[(4-metoxi-3,5-dimetil-2-piridinilo) metil] sulfinil]-(9CI), 1H-Bencimidazol, [6-metoxi-2-[(4-metoxi-3,5-dimetil-2-piridinilo) metil] sulfinil]-, 1H-Benzimidazole 5-methoxy-2-[[(4-methoxy-3 5-dimethyl-2-pyridinyl)methyl]sulfinyl]-(9CI), 1H-Benzimidazole 5-methoxy-2-[[(4-methoxy-35-dimethyl-2-pyridinyl)methyl]sulfinyl]-(9CI), 1H-Benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, 2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-5-methoxy-1H-benzo[d]imidazole, 2-[[(3 5-Dimethyl-4-methoxy-2-pyridyl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole, 5-Methoxy-2-[[(4-methoxy-3 5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole, 5-Methoxy-2-[[(4-methoxy-3 5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole, 6-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole, (S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole, 326602-80-6, 88546-55-8, 95510-70-6,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited